Literature DB >> 14699385

Oral pemphigus vulgaris after anthrax vaccine administration: association or coincidence?

Matthew Muellenhoff1, Tiffany Cukrowski, Michael Morgan, David Dorton.   

Abstract

Pemphigus vulgaris is an autoimmune blistering disorder of the skin and mucous membranes. Numerous medications, ultraviolet light, and radiation have all been implicated in the etiology of the disease. We present a patient with pemphigus vulgaris whose disease developed after administration of anthrax vaccine. The histologic and immunofluorescence findings were characteristic of pemphigus vulgaris. Adverse systemic events associated with the anthrax vaccine consist primarily of flu-like symptoms. Previous cases of pemphigus vulgaris associated with anthrax vaccine administration have not been reported. Considering the recent deliberate outbreaks of anthrax and continued threats of bioterrorism, the potential exists for widespread administration of the anthrax vaccine. Accordingly, continued observation and documentation of true adverse events is needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14699385     DOI: 10.1016/s0190-9622(03)00407-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.

Authors:  Ajeet Singh; Sujana J Bharadwaj; Anju G Chirayath; Satyaki Ganguly
Journal:  J Cosmet Dermatol       Date:  2022-04-09       Impact factor: 2.189

2.  Pemphigus foliaceus triggered after inactivated SARS-CoV-2 vaccine: Coincidence or causal link?

Authors:  Sofia Alami; Leila Benzekri; Karima Senouci; Mariame Meziane
Journal:  Dermatol Ther       Date:  2022-08-28       Impact factor: 3.858

3.  Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective.

Authors:  Marta Mazur; Irena Duś-Ilnicka; Maciej Jedliński; Artnora Ndokaj; Joanna Janiszewska-Olszowska; Roman Ardan; Malgorzata Radwan-Oczko; Fabrizio Guerra; Valeria Luzzi; Iole Vozza; Roberto Marasca; Livia Ottolenghi; Antonella Polimeni
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.